| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Executive VP of R& D
1 company
Avijit K. Ray-Chaudhuri last filed a Form 4 in October 2024, as Executive VP of R& D at AEHR. Avijit K. Ray-Chaudhuri's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Historically, Avijit K. Ray-Chaudhuri's trades have earned a below-average insider score of 25/100 across 3 rated trades. Over a 12-month horizon, none of those trades were profitable, with an average 12-month return of -15.7%.
At the last filing, the largest reported position was 28,318 shares of AEHR. Net of sales, the AEHR filings show accumulation of 8,041 shares.
Avijit K. Ray-Chaudhuri has 10 Form 4 filings on record from January 2024 to October 2024, all as Executive VP of R & D at Aehr Test Systems (AEHR), 2024.
The 11 reported transactions were 5 tax withholdings, 3 open-market purchases, 2 other transactions and 1 stock award.
Counted by filing, the open-market trades come to 2 purchases worth about $151K and no sales.
The largest open-market purchase was 5,041 shares of AEHR at an average $19.41 on July 19, 2024, about $98K. Twelve months later AEHR was down 21%.
Shares as reported in the last Form 4 for each company; the most recent is from October 2024. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.